These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15797885)

  • 1. Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?
    Rubio G; Ponce G; Rodriguez-Jiménez R; Jiménez-Arriero MA; Hoenicka J; Palomo T
    Alcohol Alcohol; 2005; 40(3):227-33. PubMed ID: 15797885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
    O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
    J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of naltrexone in the treatment of alcohol dependence disorder in women].
    Ponce G; Sánchez-García J; Rubio G; Rodríguez-Jiménez R; Jiménez-Arriero MA; Palomo T
    Actas Esp Psiquiatr; 2005; 33(1):13-8. PubMed ID: 15704026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
    Lapham S; Forman R; Alexander M; Illeperuma A; Bohn MJ
    J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of outcome from an Australian pharmacological relapse prevention trial.
    Morley KC; Teesson M; Sannibale C; Baillie A; Haber PS
    Alcohol Alcohol; 2010; 45(6):520-6. PubMed ID: 20952764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study.
    Caputo F; Addolorato G; Stoppo M; Francini S; Vignoli T; Lorenzini F; Del Re A; Comaschi C; Andreone P; Trevisani F; Bernardi M;
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):781-9. PubMed ID: 17611081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of compliance with naltrexone among alcoholics.
    Rohsenow DJ; Colby SM; Monti PM; Swift RM; Martin RA; Mueller TI; Gordon A; Eaton CA
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1542-9. PubMed ID: 11045863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naltrexone on alcohol self-administration in heavy drinkers.
    Davidson D; Palfai T; Bird C; Swift R
    Alcohol Clin Exp Res; 1999 Feb; 23(2):195-203. PubMed ID: 10069545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone in the treatment of alcoholism: predicting response to naltrexone.
    Volpicelli JR; Clay KL; Watson NT; O'Brien CP
    J Clin Psychiatry; 1995; 56 Suppl 7():39-44. PubMed ID: 7673104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan.
    Huang MC; Chen CH; Yu JM; Chen CC
    Addict Biol; 2005 Sep; 10(3):289-92. PubMed ID: 16109592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alcohol dependence treatment with naltrexone: safety assessment. Observation study group of alcoholic dependence].
    Ochoa Mangado E; Arias Horcajadas F; Torres Hernández MA
    Actas Esp Psiquiatr; 2000; 28(3):161-8. PubMed ID: 11000698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders.
    Lapham SC; McMillan GP
    J Addict Med; 2011 Sep; 5(3):163-9. PubMed ID: 21844831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.